Hersima 440 Mg Injection

Description

Hersima 440mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient, Trastuzumab, is a monoclonal antibody that specifically targets the HER2 protein. Many cancer cells, particularly in breast and gastric cancers, overexpress the HER2 protein, which promotes their growth and proliferation. Hersima works by binding to these HER2 receptors on cancer cells, blocking the signals that tell the cells to grow and divide. It can also flag cancer cells for destruction by the body’s immune system. Hersima is typically administered intravenously by a healthcare professional. The dosage and duration of treatment are determined by the specific type and stage of cancer, as well as the patient’s individual response. Common side effects may include fever, chills, nausea, vomiting, diarrhea, and fatigue. Less commonly, it can cause heart problems or severe allergic reactions. Storage instructions should be followed as per the manufacturer’s guidelines, typically requiring refrigeration and protection from light. Always consult with your healthcare provider for personalized medical advice regarding Hersima.